This inventor holds 3 USPTO granted patents. Top assignees: Ferring Ab, Ferring B.v.. Active years: 1997-1999.
Company Filing History:
Years Active: 1997-1999
Title: Innovations of Lars Henrik Andersson
Introduction
Lars Henrik Andersson is a notable inventor based in Lund, Sweden. He has made significant contributions to the field of cyclic peptide synthesis, holding a total of 3 patents. His work focuses on improving the efficiency and cost-effectiveness of peptide production, which has important implications in pharmaceuticals.
Latest Patents
Andersson's latest patents include innovative processes for preparing and purifying cyclic peptides that contain disulfide moieties. One of his patents describes a two-step processing operation that utilizes reverse phase chromatography. This method simplifies the synthesis process, reduces production costs, and yields high-quality results. It is particularly beneficial for the preparation of vasopressin and oxytocin, along with their respective derivatives and analogs. Another patent outlines a single processing operation that also simplifies synthesis and lowers costs. This method achieves higher yields by isolating the desired cyclic compound through direct ion exchange chromatography, making it an integral part of the process.
Career Highlights
Throughout his career, Lars Henrik Andersson has worked with prominent companies such as Ferring AB and Ferring B.V. His expertise in peptide synthesis has positioned him as a valuable asset in the pharmaceutical industry.
Collaborations
Andersson has collaborated with various professionals in his field, including Jan-Ake Skoldback, enhancing the impact of his innovations.
Conclusion
Lars Henrik Andersson's contributions to cyclic peptide synthesis demonstrate his commitment to advancing pharmaceutical processes. His innovative patents reflect a deep understanding of the complexities involved in peptide production, ultimately benefiting the industry and its applications.